Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
3 No-Brainer Growth Stocks to Buy in October
07:15am, Sunday, 13'th Oct 2024
These stocks look like slam-dunk picks for growth investors.
Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
06:12am, Friday, 11'th Oct 2024
Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in the world's most populous nation by beefing up senior leadership in India a
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
08:03am, Thursday, 10'th Oct 2024
U.S. Senator Elizabeth Warren has asked antitrust regulators to closely scrutinize a $16.5 billion deal in which Novo Nordisk's controlling shareholder would acquire contract drug manufacturer Catalen
2 No-Brainer Dividend Growth Stocks to Buy Right Now
06:45am, Thursday, 10'th Oct 2024
These two pharmaceutical giants are positioned for growth with their innovative diabetes and obesity treatments.
Got $5,000? These 3 Growth Stocks Are on Sale Right Now.
10:07am, Wednesday, 09'th Oct 2024
These stocks are all down 14% or more in the past three months.
Novo Nordisk (NVO) Stock Declines While Market Improves: Some Information for Investors
06:51pm, Tuesday, 08'th Oct 2024
Novo Nordisk (NVO) closed the most recent trading day at $117.20, moving -0.48% from the previous trading session.
Prediction: 3 of Wall Street's Most Influential Stocks Can Plunge if Kamala Harris Wins in November
05:06am, Tuesday, 08'th Oct 2024
A victory for the current vice president on Nov. 5 may be bad news for three market-leading businesses.
Novo Nordisk launches new initiative to prevent childhood obesity in disadvantaged urban communities
04:00am, Tuesday, 08'th Oct 2024
Bagsværd, Denmark, 8 October 2024 – Novo Nordisk today announced a new global initiative to prevent obesity in children. The Childhood Obesity Prevention Initiative aims to accelerate the preventio
Novo Nordisk A/S – Share repurchase programme
06:44am, Monday, 07'th Oct 2024
Bagsværd, Denmark, 7 October 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Counc
Novo Nordisk downgraded amid supply bottlenecks
06:24am, Monday, 07'th Oct 2024
Jefferies has downgraded its rating on Novo Nordisk (NYSE:NVO) to "underperform" and cut its price target to DKK 575, down from the previous DKK 782.90. The downgrade comes amid concerns over the supp
Prediction: These 2 Stocks Will Join Nvidia, Meta, Apple, Amazon, and Microsoft in the Trillion-Dollar Club by 2030
06:00am, Sunday, 06'th Oct 2024
These companies have been on fire for a while, but they haven't peaked yet.
Novo Nordisk to invest $158 million in insulin plant in Brazil
02:58pm, Friday, 04'th Oct 2024
Danish drugmaker Novo Nordisk will invest 864 million reais ($158.2 million) to revamp a plant in Brazil responsible for pumping out a quarter of its insulin production globally, the firm said on Frid
Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know
10:05am, Friday, 04'th Oct 2024
Zacks.com users have recently been watching Novo Nordisk (NVO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn't a Problem.
09:48am, Wednesday, 02'nd Oct 2024
The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter.
Wegovy and Ozempic drive impressive prescription growth, says Citi
11:26am, Monday, 30'th Sep 2024
Analysts from Citi are bullish about the GLP-1 market, particularly within obesity and diabetes treatments, signaling a positive outlook for key players despite facing some supply constraints. Accord
